香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 本公告不會直接或間接於或向美國（包括美國的領土及屬地、美國任何州以及哥倫比亞特區）發 佈、刊發或派發。本公告並不構成亦不屬於在美國境內或於任何其他司法管轄區購買或認購發 售股份的任何要約或招攬的一部分。本公告所述發售股份並無亦不會根據《1933年美國證券法》 （經不時修訂）（「美國證券法」）或美國任何州或其他司法管轄區的證券法登記。發售股份不得 在美國境內提呈發售、出售、質押或以其他方式轉讓，惟獲豁免遵守美國證券法及《美國1940 年投資公司法》（「美國投資公司法」）登記規定及符合任何適用的州證券法則另作別論。發售股 份：(1)僅根據美國證券法第144A條或美國證券法或任何適用的州證券法的其他可用登記豁免 規定向合資格機構買家（定義見美國證券法第144A條）及合資格買家（定義見美國投資公司法第 2(a)(51)條）提呈發售及出售；及(2)於美國境外向非 ...

Group 1 - The company, Lakala Payment Co., Ltd., announced an abnormal fluctuation in its stock trading on June 13, 2025, which is in accordance with the relevant regulations of the stock exchange [1] - The company's board of directors conducted inquiries with major shareholders and management regarding the stock's abnormal trading situation and confirmed that there are no undisclosed major matters currently in the planning stage [1] - The board confirmed that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange's rules, and previous disclosures do not require correction or supplementation [1]

Core Viewpoint - Lakala's H-share listing faces significant uncertainty regarding its approval, filing, and review processes [1] Group 1: Company Actions - Lakala has conducted a self-examination and found no violations of fair information disclosure [1] - The company is in discussions with relevant intermediaries about the specific progress of the H-share listing [1] Group 2: Regulatory Requirements - The H-share listing plan will need to be submitted for approval by the company's board and shareholders [1] - Approval from the People's Bank of China, filing with the China Securities Regulatory Commission, and review by the Hong Kong Stock Exchange are required [1] Group 3: Investment Considerations - There is a high level of uncertainty regarding whether the H-share listing will ultimately be approved and implemented [1] - Investors are advised to be cautious of investment risks associated with this uncertainty [1]

Group 1 - The company announced plans to initiate the process for issuing H-shares and listing on the Hong Kong Stock Exchange to enhance its international presence and brand recognition [1] - The board of directors has authorized the management to start preparatory work for the H-share listing, with a timeframe of 12 months from the board's approval [1] - The H-share listing is subject to further approval from the board, shareholders, and relevant regulatory bodies including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [1] Group 2 - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 15, 2019, with an issuance of 83.47 million shares at a price of 18.26 yuan per share [2] - The total funds raised from the initial public offering amounted to 152.42 million yuan, with a net amount of 145.02 million yuan after deducting issuance costs [2] - The funds raised were intended for various projects including the production line for inorganic ceramic nanofiltration membranes and a research center for membrane materials and technology [2][3]

Core Viewpoint - Anjiu Food Group Co., Ltd. is in the process of applying for the issuance of H-shares and listing on the Hong Kong Stock Exchange, with the application submitted on January 20, 2025 [1][2]. Group 1: Application Process - The company submitted its application for H-share issuance and listing to the Hong Kong Stock Exchange on January 20, 2025, and published the application materials on the same day [1]. - On May 15, 2025, the China Securities Regulatory Commission confirmed the company's H-share issuance and listing filing [2]. - A listing hearing was held by the Hong Kong Stock Exchange Listing Committee on June 5, 2025, to review the company's application [2]. Group 2: Information Disclosure - The company published a post-hearing information package on the Hong Kong Stock Exchange website, which is intended solely for public information and may be updated [3]. - The company will not publish the post-hearing information package on domestic stock exchanges but provides links for domestic investors to access the information [3]. - The announcement clarifies that the information provided does not constitute an offer or invitation to purchase any securities [3]. Group 3: Regulatory Approval - The issuance and listing of H-shares are subject to final approval from relevant regulatory bodies, including the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange, indicating uncertainty in the process [4].

证券代码：002459 证券简称：晶澳科技 公告编号：2025-051 债券代码：127089 债券简称：晶澳转债 晶澳太阳能科技股份有限公司 关于召开 2024 年度股东大会的会议通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 晶澳太阳能科技股份有限公司（以下简称"公司"）第六届董事会第四十次会议 决议召开公司 2024 年度股东大会（以下简称"会议"），现就会议有关事项通知如 下： 一、召开会议的基本情况 （一）股东大会届次：2024年度股东大会 （二）会议召集人：公司第六届董事会 （三）本次会议经公司第六届董事会第四十次会议决议召开，本次股东大会会 议的召开符合有关法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 （四）会议召开日期和时间 和13:00—15:00；通过深圳证券交易所互联网投票系统进行网络投票的开始时间为 东大会结束当日）15:00。 （五）会议召开方式：本次会议采取现场投票与网络投票相结合的方式，公司 将通过深圳证券交易所交易系统和互联网投票系统向公司股东提供网络形式的投票 平台，股东可以在网络投票时间内通过上述系统行使 ...

金十数据6月4日讯，锦江酒店公告称，于2025年6月4日召开第十届董事会第四十一次会议及第十届监事 会第二十二次会议，分别审议通过了《关于公司聘请H股发行及上市的审计机构的议案》，同意公司聘 请毕马威会计师事务所为公司本次H股上市的审计机构，为公司出具本次H股上市相关的会计师报告并 就其他申请相关文件提供意见；并聘请其担任公司完成本次H股上市后首个会计年度的境外审计机构。 锦江酒店：聘请H股发行及上市审计机构 ...